RIPK3’s shape-shifting scaffold: how kinase domain conformation fine-tunes necroptosis

Necroptosis is a tightly regulated form of cell death that culminates in membrane rupture and the release of inflammatory damage-associated molecular patterns [ 1 ]. Once considered merely cellular accidents, programmed necrotic death pathways have emerged as sophisticated biological mechanisms with ancestral roots in host defence against pathogens [ 2 ]. The molecular execution of necroptosis is orchestrated by receptor-interacting serine/threonine-protein kinase 3 (RIPK3), which phosphorylates and activates the pseudokinase mixed lineage kinase domain-like protein (MLKL). Upon RIPK3-mediated phosphorylation within its pseudokinase domain activation loop, MLKL undergoes conformational changes that promote its oligomerization, translocation to the plasma membrane, and insertion into the lipid bilayer that culminates in membrane permeabilization and cell lysis [ 3 ]. In an elegant study now published in Cell Death & Differentiation , Chiou et al. challenge the prevailing view of RIPK3 as solely a catalytic activator of MLKL [ 4 ]. Their findings reveal that the three-dimensional conformation of RIPK3’s kinase domain, independent of its enzymatic activity, functions as a molecular rheostat that dynamically tunes cellular commitment between necroptotic and apoptotic death pathways.